Current Chinese Medical Science

Prof. Atta-ur-Rahman, Ph.D. in organic chemistry from Kings College, University of Cambridge (1968), has 1235 international publications in several fields of organic chemistry including, 349 books published largely by major U.S. and European presses. He was elected as Fellow of Royal Society (London) (2006) and won the prestigious UNESCO Science Prize (1999). Prof. Atta-ur-Rahman was conferred honorary D.Sc. degrees by many leading world universities including the University of Cambridge and appointed an Honorary Life Fellow of Kings College, University of Cambridge. The Austrian government honoured him with its high civil award (“Grosse Goldene Ehrenzeischen am Bande") (2007). He is Professor Emeritus at the University of Karachi, Pakistan. Prof. Atta-ur-Rahman was appointed Academician (Foreign Member) of the Chinese Academy of Sciences (2015). He won the “Friendship Award of China” (2014) and was conferred the highest scientific award of China, the International Science & Technology Cooperation Award, by President Xi Jinping (2020). He was bestowed with the International Scientific Corporation Award (2014) and the “Einstein Professorship” by the Chinese Academy of Sciences (CAS) (2013). He was also elected as Foreign Member of the Korean Academy of Science and Technology. Research Institutes have been established in his name in China, Malaysia and Pakistan.

Dr. Xiong Z. Ruan is currently the Director of the Joint Centre for Lipid Research in Chongqing Medical University and University College London. He received his MBBS in Southeast University Medical School in 1988, M.Sc. in Peking Union Medical College Hospital (PUMCH) in 1994 and PhD from University College London (UCL) in 2000. He is the UCL-China Steering Committee Member. He is the President-elect of Chinese Association of Renal Physiology, Vice-President of Chinese Society of Lipid and Lipoprotein, and Vice-President of Chinese Medical Doctor Association of Fatty Liver Disease. His main goal has been to develop an academic research programme for ‘lipids and tissue injury (liver, kidneys and vessels) which involve multi-organ cross-talks in UK and China that investigates the molecular mechanisms for metabolic diseases. He has published more than 120 papers in different scientific journals.

Dr. Li is a Professor of Neurobiology and Neurogenetics at Jinan University, Guangzhou, China. He also serves as deputy-director of Clinical Neuroscience Institute of Jinan University, Guangzhou. He graduated from the Jilin University in Changchun with a BSc in Biochemistry in 1993 and obtained Ph.D. in Molecular Epidemiology from Harbin Medical University in 2004. Dr. Li’s laboratory focuses primarily on identifying genetic variants that modulate the risk of Alzheimer’s disease and other neuropsychiatric disorders. For this purpose, his group combines genomic, genetic and bioinformatics approaches to gain predictive insights into these diseases.

Prof. Xiao is currently a Post doctor at Peking University. He did his PhD in 2005 from Sheng Yang Pharmaceutical University. His fields of expertise are Biotransformation of bioactive natural products, Isolation and structural determination of chemical constituents from natural resources, the metabolism of natural products, QC of medicinal herbs by HPLC analysis. He has worked on the investigation on the manual incubation of rare medicinal plants and fungi. He also investigated phytochemistry of 5 traditional Chinese medicines, and purified and identified over 130 chemical constituents by modern chromatographic and spectral techniques, 15 of which are new chemical entities.

Dr. Qinghua Wu got the doctor's degree from Huazhong Agricultural University, China in 2013. During 2010-2011, Dr. Wu has studied as a visiting scholar in Institute of Food Chemistry, University of Muenster, Germany. Since 2014, he is an invited professor in University of Hradec Kralove. Since 2015.07, he began to be an associate professor in Yangtze University. His research interest is metabolism, pharmacokinetics, toxicokinetics, immunotoxicity, and food safety. Dr Wu has published more than 50 peer-reviewed articles in the field of metabolism and toxicology.

James Adams received his PhD in Pharmacology from the University of California San Francisco. He has been a Professor at the University of Southern California School of Pharmacy for 28 years, where he teaches Pharmacy, Medical and Graduate Students. He has over 250 publications in journals and books. His current area of interest is California medicinal plants. Dr. Adams was trained in Chumash Indian Healing for 14 years by a recognized Chumash Healer. Since 2012, he has become a Healer to the Chumash people of the San Fernando Valley. He has written a book and several articles on Chumash Healing. He continues to teach Chumash Healing to healthcare students and the public.

Professor Ernest Adeghate obtained his medical degree from Semmelweis University Medical School, Budapest, Hungary and his PhD and DSc from the Hungarian Academy of Sciences. He also has a Master degree in Family Medicine from Monash University, Australia. He is interested in the morphology of pancreatic grafts and the effect of neurotransmitters, neuropeptides and cytokines on parameters of metabolic disease, insulin release and on complications of diabetes mellitus. Prof. Adeghate has published more than 200 peer-reviewed articles. He is currently, the Editor-in Chief of The Open Medicinal Chemistry Journal published by Bentham Science Publishers.

Dr. Muhammad Akram, PhD, is currently an assistant professor at the department of Eastern Medicine, Directorate of Medical Sciences, Faculty of Science and Technology, Government College University Faisalabad. His research interests are Hyperuricemia, Xanthine oxidase inhibition by some selected medicinal plants, Enzyme Inhibition, Study of traditional system medicine (Indusyunic Medicine) Phytochemistry, and poisonous plants. He has contributed more than 96 publications, having citations around 419.

Fabio Angeli is a Cardiologist and Biomedical researcher trained in cardiovascular medicine, particularly in the context of cardiovascular risk assessment, diabetes, kidney diseases, heart failure, acute coronary syndromes and maternal and neonatal healthcare. He has published more than 160 papers in reputed journals indexed by PubMed and has been serving as an editorial board member of several international leading Journals.

Prof Suleyman Aydin has received his PhD in Illinois Institute of Technology during the period of 1999. Currently, he is working at Medical School as Professor of Medical Biohemistry in Firat University. He has authored more than 175 research articles/books. He is currently also serving as scientific Reviewer for various academic journals He is a member of Organization Committee Members, Council Members,, The American Turkish Society, Turkish Biochemical Society and The Endocrine Society). He has honoured as Certificate in Laboratory Animal Science, Good Clinical Practice (GCP) and statistics, Certificate in Clinical Trial, Trainer’s Training Certificate and Pedagogical Formation Training Certificate.

Dr. H J Biersack is a Director of Department of Nuclear Medicine at university of Bonn. His honours include Order of Merit/Fed.Republik of Germany, Sign of Honor/Red Cross, Werner Heisenberg-Medaille 2000. He received Alfred-Gütgemann-Award 1979. His research of Nuclear Medicine in the Diagnosis of diseases of the liver, the heart, the skeleton and the brain; diagnosis and therapy of thyroid diseases; during the last 10 years mainly brain research (neurophysiology, epilepsy, cerebro-vascular diseases, brain tumors); coordination of an interdisciplinary group on brain research (Faculties of Medicine, Natural Sciences, and Philosophy); during the last 6 years PET/CT and SPECT/CT in oncology as well as radionuclide therapy in NET, SD-Ca and liver tumors (SIRT).

Prof. Arnon Blum received his MD at the Technion, specialized in Internal Medicine at Hebrew University, and then in Cardiology at Tel-Aviv University. He served in the IDF as a Flight Surgeon (Lieutenant Colonel). Since 1999 Prof. Arnon Blum has been the Director of the Internal Medicine Ward at Baruch Padeh Medical Center-Poriya, Tiberias. Prof. Blum further concentrated on Vascular Biology and Vascular Stem Cell research, receiving his training at the National Institutes of Health (Bethesda, MD, USA; 1997-1999 and 2006-2008) exploring means for cardio-vascular regeneration.

Tao Huang is an Associate Professor and Director of Bioinformatics Core Facility at Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. He completed his post-doctoral research at Department of Genetics and Genomics Sciences, Icahn School of Medicine at Mount Sinai, New York City, USA. His research interests include bioinformatics, machine learning and big data research. He has published over 150 articles. His works have been cited for 5261 times with an h-index of 32 and an i10-index of 99.

Kamil Kuca is working for several academic institutes (University of Hradec Kralove, Czech Republic; University Hospital Hradec Kralove, Czech republic; Florida International University, USA; Yangtze University, China; etc.). He is recently rector of the University of Hradec Kralove. He was also technology scout focused on biomedicine in the past. His research interests are toxicology, pharmacology, drug design, technology transfer, pharmacoeconomy, chemical and biological terrorism, etc. He was/is principal investigator on numerous national and international projects (EU, NATO, GACR, IGA MZ, MSMT etc.). He has published more than 350 IF research papers. He is working with several companies as a scientific consultant. He has lots of cooperators throughout the world (e.g. Korea, Croatia, United Arab Emirates, USA, France, Turkey, China, Singapore, Sweden, and Brazil). His Hindex is 36, number of citation in WoS is over 3000.

Dinesh Kumar, PhD, M.Sc. Dr. Dinesh started his research career in Aug 2005 in the field of biomolecular NMR and currently, he is working as an Assistant Professor at the Centre of Biomedical Research (CBMR), Lucknow, India. The primary area of his research is NMR based metabolomics for disease metabotyping i.e. to identify the disease specific metabolic signatures and to appraise their utility in clinical diagnosis and surveillances. Parallelly, he is also involved in developing NMR methods and protocols for rapid structural and functional studies of proteins. During his 11 years of research career, he has authored more than 35 research publications, several conference papers, 1 patent and has delivered several invited lectures. His research work in the area of biomolecular NMR, particularly, the developed NMR methodologies have been well recognized both nationally as well as internationally as demonstrated by his getting "2011 Eli Lilly Outstanding Thesis Award in Structural Biology" and CBMR-NMRS gold medal from National Magnetic Resonance Society (NMRS), India for the year 2013.

Chiu Mok is currently the chief of the Division of Rheumatology, Department of Medicine, Tuen Mun Hospital, Hong Kong. He is a consultant physician and adjunct teaching professor of the Chinese University of Hong Kong. An active researcher, Dr. Mok is the first author of more than 200 papers in a number of medical and Rheumatology journals that include the Annals of the Rheumatic Diseases, Nature Review Rheumatology, Arthritis and Rheumatology, Rheumatology (Oxford), and Arthritis Care & Research. His research interests include systemic lupus erythematosus, particularly lupus nephritis, and glucocorticoid induced osteoporosis. Dr. Mok is also the principal investigator of more than 10 phase II/III global trials investigating the safety and efficacy of novel biological agents in various rheumatic diseases. Dr. Mok is currently the senior associate editor of the International Journal of Rheumatic Diseases and an editorial member of more than 10 medical journals that include the Journal of Rheumatology, Lupus, Current Rheumatology Review, Open Orthopedic Journal and Immunology and Immunogenetic Insights. Dr. Mok is a Past President of the Hong Kong Society of Rheumatology. He is the founder editor of the Journal of Clinical Rheumatology and Immunology, the official publication of the Hong Kong Society of Rheumatology.

Professor Nisheeth C Desai, Professor Nisheeth C Desai had obtained his Ph.D degree from Bhavnagar University in 1982 in the field of Medicinal Chemistry and 33 years of teaching and research experience. Till date he has produced 40 Ph.D students and currently six students are working for their Ph.D degree and two students have completed post-doctoral research under his guidance. Till date, published more than 110 research papers in the national and international journals. Main interest he had developed in the field of synthesis of bio-active hetercyclic molecules, antimicrobial, antitubercular, anticancer screening, green chemistry and intellectual property and its management in academic institutes. Received prestigious Carrier Award for young scientist by University Grants Commission, New Delhi in 1995.

Prof.Dr. Ilkay Erdogan Orhan holds a Pharmacist degree (1993) from Gazi University (Ankara, Turkey), M.Sc. degree at Department of Pharmacognosy at the same faculty in 1996 with young scientist scholarship provided by TUBITAK (Technical and Scientific Research Council of Turkey). Then, she was awarded her second M.Sc. degree in Marine Natural Product Chemistry in 1998 at the University of the Ryukyus in Japan supported by Monbusho scholarship. She earned Ph.D. degree in Pharmacognosy at Faculty of Pharmacy, Gazi University, Ankara, Turkey in 2002 and worked as visiting scientist at Department of Chemistry at University of Winnipeg (Canada) in 2003 under NATO-TUBITAK fellowship program. She was promoted to Assoc.Prof. position by Higher Education Council of Turkey in 2004 and became full professor in 2009. Dr. Orhan Dr. was appointed as “Dean” of Faculty of Pharmacy at Eastern Mediterranean University in the Northern Cyprus for the period of 2011-2014 and currently, she is Dean of Faculty of Pharmacy, Gazi University since 2016. She is also member of Traditional Chinese Medicine (TCM) Experts Group in European Pharmacopeia as well as member of the International Scientific Board of Austrian Drug Screening Institute (ADSI).

Dr. Prabhakar is a Chief Scientist & Professor, AcSIR in CSIR-Central Drug Research Institute, Lucknow, India. He has 35 years research experience in computer-aided drug design and discovery processes. His research is focused on molecular modeling of agents against infectious and vector borne diseases. Dr. Prabhakar has authored more than 80 manuscripts, two book chapters, one patent, and co-edited a thematic issue of Current Computer-Aided Drug Design on Chemo- and Bioinformatics of Drug Discovery of Vector Borne Diseases. He is on the panel of PhD advisers of Jawaharlal Nehru University, New Delhi and guest faculty of the National Institute of Pharmaceutical Education and Research, Raebareli, India where he teaches Medicinal Chemistry to M.S. (Pharmaceutical Chemistry) students.

Teodorico C. Ramalho obtained his BSc in Chemistry from the University of Brasília in 1999 and his Master Degree in Chemistry from the Military Institute of Engineering (IME) Rio de Janeiro, Brazil, 2001. He received his PhD in chemistry from IME and was a doctoral fellow at the Max Planck Institute für Kohlenforshung in 2004. After a post-doctoral training at the Federal University of Rio de Janeiro and University of California, he joined the Federal University of Lavras (UFLA) as a professor of Chemistry. His research interests are in the areas of medicinal chemistry, theoretical chemistry, catalysis and solid-state chemistry of molecules of biological interest.

Claudiu T. Supuran is the Professor of medicinal chemistry at the Neurofarba Department, Section of Pharmaceutical and Nutriceutical Sciences, University of Florence, Italy. He has published more than 1250 papers, his Hirsch factor is h = 110; the number of citations since 1995 > 49800. His main research interest is on enzyme inhibitors, and especially carbonic anhydrase inhibitors, of which he discovered several new classes in the last years. One of the sulfonamides discovered in his group entered Phase I clinical trials in 2014 for the treatment of advanced, metastatic solid tumors. He is the Editor-in-Chief of Expert Opinion on Therapeutic Patents, Journal of Enzyme Inhibition and Medicinal Chemistry, Current Enzyme Inhibition, etc. For the last 25 years the main interest of his research was focused on metallo-enzymes and their modulators of activity. In 2013, he was rated as the most cited scientists in Pharmacology & Toxicology by LabTimes (LabTimes 2013, 5, 38).

Francisco Torrens is lecturer in physical chemistry at the Universitat de València. After obtaining a PhD in molecular associations in azines and macrocycles from the Universitat de València, Dr. Torrens undertook postdoctoral research with Professor Rivail at the Université de Nancy I. More recently, Dr. Torrens has collaborated on projects with Professors Tomás-Vert, Salgado and Castellano. Major research projects include prediction of the environmental impact of chemical substances using chemobioinformatics tools, discovery of new inhibitors of tyrosinase: computational design, synthesis, characterization and experimental corroboration, search for new antimicrobial agents that inhibit the synthesis of the bacterial cell wall, minimal active domains of proteins of the Bcl2 family, development and application of quantum chemistry methods and techniques to studies of drugs, analysis of pores of BAX at nanometric scale and study of the in vivo antioxidant capacity of phenolic compounds through QSAR/QSPR modelling: crossing of the blood-brain barrier and interactions with cytochromes and drugs. His scientific accomplishments include the first implementation in a computer at the Universitat de València of a program for the elucidation of crystallographic structures and the construction of the first computational-chemistry program adapted to a vector-facility supercomputer in a Spanish university.

Chun-Wei Tung is an associate professor in Graduate Institute of Data Science, Taipei Medical University, Taiwan. He is also an adjunct assistant research fellow in National Environmental Health Research Center, NHRI, Taiwan. His research interests include bioinformatics, immunoinformatics and toxicoinformatics. He is also a member of IAPR TC-20 (Technical Committee on Pattern Recognition in Bioinformatics)

He is Associate Professor, Deputy Director of Institute of Chinese Herbal Medicine Beijing and Associate Director of Integrative Medical Center for Liver Diseases, Beijing 302 Hospital of China His main research focus is the evaluation of drug- and herb- induced liver. My team has developed a new causality identification algorithm for HILI diagnosis, new approaches for in vitro and in vivo evaluation of hepatotoxicity, evaluation models for susceptibility of DILI/HILI. Recently, he established the online database of HILI (hilidatabase.org) in response to a Major Project launched by the NSFC to provide a platform for global collaborative research of HILI.

Dr. Yee obtained a medical doctorate (M.D.) and a doctorate (Ph.D.) in Molecular Biology from Cornell University. Currently, Dr. Yee is an Assistant Professor of Medicine in Hematology and Oncology in the Pennsylvania State University College of Medicine. He is also a medical oncologist in the PennState Cancer Institute, and an attending and consultant physician in the PennState Milton S. Hershey Medical Center. He has published extensively in basic, translational, and clinical sciences, including original research articles, review articles, book chapters, and clinical case reports. Dr. Yee is currently the Regional Editor of this journal (Clinical Cancer Drugs), published by Bentham Science Publishers.

Dr. Zhang focuses on the methodological and application studies on elucidating the action mechanisms of Chinese herbal formulae, which is one of the kernel scientific problems in the research field of traditional Chinese medicine. She has accomplished several innovative achievements including the development of novel methods to clarify the dynamic characteristics of disease progression based on regulatory network of biological molecules, as well as the establishment of global analysis strategy to investigate the action mechanisms of herbal formulae based on the target prediction technology for herbal ingredients and the explanation for "disease therapeutics target-drug target interaction network".

Yun Zhang is a scientist at Shandong Academy of Sciences, a scientific research institution focusing on drug screening and biotechnology. She has a good experience in screening and evaluating the activities of compounds using zebrafish models, mainly including anti-angiogenic activity, pro-angiogenic activity, anti-tumor metastasis activity (transplanted cancer model), organ protection activity (protecting cardiac, renal and liver), anti-apoptosis activity, and assay of acute toxicity, developmental toxicity, cardiotoxicity and hepatotoxicity. She has published her research work in various peer reviewed journals. And she has applied for 23 patents, of which 8 were authorized.

Dr. Ying-Yong Zhao (PhD, MD) is professor at Department of Traditional Chinese Medicine, Northwest University in China. Zhao has authored more than 100 peer-reviewed publications and three books. He received several awards including Sanofi Young biological drugs Award and Fifteenth SERVIER Youth Pharmacology Award. He serves as an editor-in-chief of Journal of Nephrology Advances and editorial board member for 13 international journals including Journal of Nephrology & Therapeutics, Current Metabolomics and Journal of Nephrology and Urology Research. He is a reviewer of more than 30 famous international journals, including Nature Review Nephrology, Kidney International and CJASN in the area of pharmacology and metabolomics studies. His areas of expertise include pharmacology and metabolomics from natural products. His work is mainly focus on chronic kidney disease and therapeutic effect of natural products by pharmacology and metabolomics. He also is studying the oxidative stress, inflammation, and pro-fibrotic pathways of chronic kidney disease.

Kurt S. Zäenker, a Professor at the University of Witten/Herdecke, Germany, is an immunologist and a tumor immunologist. He has authored and co-authored more than 650 publications and edited 24 books and special issues of journals. His research focuses on basic sciences in cell migration, a molecular pre-requisite for metastasis formation, and on cell fusion, a pre-requisite for new hybrid cell entities. In his role as an editor-in-chief and member of multiple scientific boards, review committees and scientific organizations, he takes responsibility for highest standards in research communication and development and education in medical science, and organized more than 20 internationally recognized conferences.

Haji Akber Aisa is a professor and the vice president of Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Science (CAS) and the director of Central Asian Center of Drug Discovery and Development of CAS. He received his Doctoral Degree in Shanghai Institute of Materia Medica, CAS. He was supported by National Science Fund for Distinguished Young Scholars by National Natural Science Foundation of China in 2009. His research works is concentrated on modernization of traditional medicine. The studies mainly focus on: a) resources and chemistry of traditional medicinal plants in arid zone and Central Asia; b) promotion of traditional medicine and new drug development. He has published more than 300 scientific articles and more than 100 patents.

Meiwan Chen received her PhD from Sun Yat-Sen University, China and was a visiting scholar from 2009 to 2010 at University of Mississippi. At present, she is an Associate Professor at Institute of Chinese Medical Sciences, University of Macau and specializes in biomaterial and nanomedicine, especially the development of targeted drug delivery systems for cancer therapy. The research ranges from design and synthesis of novel lipidic and polymeric carriers to mechanistic understanding of delivery barriers and to in vivo studies of relevant tumor models. She has published more than 150 peer-reviewed papers in SCI journals.

Mohammed I. El-Gamal, Ph.D. is the author of more than 51 publications in highly reputed journals. He got 3 patents, and presented more than 37 posters and 8 oral presentations in different international conferences. He has peer-review more than 50 articles. And he has been an editorial board member in more than 17 international journals. He has been also a member of the Asian Council of Science Editors (ACSE). Mohammed I. El-Gamal, Ph.D. and his group have developed a new more efficient prodrug of Olmesartan (antihypertensive agent) which has been marketed in the Republic of Korea. And he is interested in anticancer, anti-inflammatory, and antimicrobial drug development.

Dr. Arda Isik is an Associate Professor in Erzincan University, Turkey. His Research Interests are Colorectal diseases, colorectal surgery, endoscopy, minimally invasive surgery, surgical oncology, trauma and emergency surgery, thyroid disease, perianal disease, hernia, breast disease,health care management, clinical and experimental research, database management, fund raising, surgical education, medical education and ethics.

Dr. Virendra Kumar is an Associate Professor in the Department NMR and MRI Facility, All India Institute of Medical Sciences, New Delhi. He received Gold Medal for his Ph.D. thesis on MR studies of prostate cancer from AIIMS, New Delhi and was a Cancer Imaging postdoctoral fellow, Department of Cancer Imaging and Metabolism, Moffitt Cancer Center, Tampa, FL, USA. Dr. Kumar is applying Radiomics, NMR metabolomics and in vivo MR methods to understand the different metabolic changes in cancer and their potential diagnostic role. He has published 54 journal research papers, 73 papers in conference proceedings and 1 book chapter.

Chaeyoung Lee is a professor in the Department of Bioinformatics and Life Science at Soongsil University in South Korea and serves as the Dean of College of Natural Sciences. He received the Ph.D. degree from Cornell University in 1995. He formerly served 12 years (1997-2008) as a professor at Hallym University. His research interests are in developing statistical and computational methods for genomics and applying the methods to complex traits. He is a primary author of more than 100 scientific papers. He has been served on the editorial boards of 10 journals.

He received the B.Eng. Degree, the M.Eng. and Ph.D. degrees in computer science from Northeast Normal University, Changchun, China in 2009, 2012, 2015, respectively. Now He is an associate professor in the Department of Computer science and information technology, Northeast Normal University. He has published more than 70 research papers. His research interests include evolutionary computation, constrained optimization, bioinformatics, computational biology, and interdisciplinary research.

Fanwang Meng studied computational drug design in Shanghai for three years, after finishing my undergraduate in pharmaceutical engineering. Now he is doing his Ph.D. at McMaster University, Canada where he focuses on using machine learning algorithms to help modern drug design, especially lead compound identification and toxicity prediction.

Dr. Ouyang received his Ph.D in Peking University (2005) and his postdoc training in University of California at San Diego (2005-2011). He was then recruited as an Assistant Research Scientist in UCSD, and joined Peking University Shenzhen Graduate School as an Associated Professor in 2013. His current lab is utilizing genetically-engineered mouse models to discover the molecular mechanisms underlying cardiovascular development and diseases.

B.Sc., Madurai Kamaraj University, India; M.Sc., Bharathidasan University, India; Ph,D., University of Madras, India, Research Fellow, NPO International Laboratory of Biochemistry, Nagoya , Japan; National University of Singapore, Singapore; Inha University, Korea Republic; University of Malaya, Malaysia; Chinese Medical University, Taiwan. The focus of my research over the past few years has been to elucidate the mechanism (s) of activation of oncogenic transcription factors by carcinogens and inflammatory agents and the identification of novel inhibitors of these proteins for prevention of and therapy for cancer.

Dr. Shalini Singh is presently working as an Assistant Professor in the Department of Chemistry, Bareilly College, Bareilly (U.P.) India. She holds a Ph.D. from A.P.S. University Rewa, (M.P). She has got awards and rewards of an unending sequence like Recipient of D.S.T. Women Scientist Scheme Award (WOS-A), U.G.C. Research Awardee 2011, Recipient of Indian Chemical Society Award-2012 Dr. Singh has contributed 42 research papers of repute with high impact factor Journal. Singh is Fellow member of Indian Chemical Society Kolkatta, India. Dr Singh is also member of many prestigious Editorials boards of national and international repute like Journal of Enzyme Inhibition and Medicinal Chemistry.

He is Responsible Cerebrovascular disease and Neurosonology in the Department of Neuroscience, Neurology Division and Stroke Unit “Annunziata” Hospital – Cosenza, Italy. He is adjunct professor at the Department of Pharmacology Department of Experimental Medicine, Faculty of Medicine, University of Catanzaro "Magna Graecia". He is editorial board in various international medical and scientific journals and reviewer in neurological journals (i.e. Neurology, stroke , European journal of Neurology). He is author and co-author of scientific publications in neurology and neuropharmacology. His recent interests are: neuropharmacology, antiepileptic drugs, epilepsy and stroke.

Dr. Wing-Leung Wong received his Ph.D. degree in Chemistry from the City University of Hong Kong in 2003. Currently, he is a Research Assistant Professor of the Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University. His research scopes include organic synthesis and catalysis, bio-recognition and sensing, and chemical biology and cell imaging.

XU, ZHENGHAO is an associate research fellow in Clinical Foundation of Chinese Medicine, Basic Medical College of Zhejiang Chinese Medical University, Hangzhou, China. He completed his PhD in neuropharmacology from Zhejiang University in 2012, received postdoctoral training in neuroscience at Zhejiang University during 2012-2014, and was a visiting scholar in neuroimmune from 2018-2019 at Duke University. He has published more than 30 peer-reviewed papers in SCI journals, such as Ebiomedicine, Neuron and Epilepsia. His research interests focuses on the pharmacological targets of Traditional Chinese Medicine (TCM) for the treatment of epilepsy and other related brain disease.

Dr.You-Hua Xu obtained his Bachelor of Medicine in Clinical Medicine and Bachelor of Arts in English (double bachelor degree) from Wuhan University of Science and Technology in 2006. He received Master of Medicine in Pharmacology from Nanjing Medical University in 2009, and PhD degree of Chinese Medicines from Macau University of Science and Technology (MUST) in 2012. Currently he is working as an Assistant Professor in the Faculty of Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau.

Graduated from China Pharmaceutical University in 2005, got a Ph.D. degree in Pharmacogonosy. The research interests focus on bioactive constituents of traditional Chinese Medicine and natural medicine on the basis of multiple fund projects. There are over ten state grade patents, ten published books edited and over one hundred published papers. The innovations won several national and provincial-level science and technology progress awards.

Dr. Yingzhuan Zhan is an Associate Professor of pharmacology and pharmaceutical science at Xi'an Jiaotong University School of Pharmacy. Her research focuses on the activity evaluation of small molecular drugs and exploring mechanisms of anti-tumor drugs. She completed her M.S. from Northwest A&F University in Shaanxi Province, China. Then, she received a Ph. D. in pharmaceutical analysis at the School of Medicine, Xi’an Jiaotong University, Shaanxi Province, China. After that, Dr. Yingzhuan Zhan joined the Xi’an Jiaotong University as a faculty in 2013. She is currently engaged in research on novel anticancer drug discovery.

Dr. Zhu completed his Ph.D. from Medical Center of Fudan University in 2002. Since 2009 till present he has been holding the position of Associate Professor at Bio-X Institutes, Shanghai Jiao Tong University. His recent research interests based on some most recent publications includes Cardiac hypertrophy and heart failure, cardiac autophagy, cardiac development and congenital heart disease and so on

Dr. Deng finalized his Ph.D. in organic chemistry from Technical Institute of Physical and Chemistry, Chinese Academy of Sciences in 2014. He is currently holding the position of Associate Professor at College of Chemistry and Life Science, and Institute of Functional Molecules, Chengdu Normal University since 2014. Based on his recent interest his research revolves around Design and preparation of organic electro-optic materials, D-π-A type organic conjugated dyes and their application, Prediction of Inhibitors by Machine Learning Approaches.

Dr. Tian Finshed his Ph. D in Statistics from ABIES (AgroParisTech at Paris) in 2013. He currently holds the position of Associated Professor at Affiliated Zhongshan Hospital of Dalian University since June 2014. His most recent research areas includes "Retrospective Long-Term Follow-Up Survival Analysis of the Management of Osteonecrosis of the Femoral Head With Pedicled Vascularized Iliac Bone Graft Transfer", "Methodological issues in meta-analysis of the metformin effects on simple obesity", "Calcium and Vitamin D Supplements and Fractures in Community-Dwelling Adults" and so on.

Dr. Yadong Zheng completed his PH. D. (Molecular Biosciences) from The University of Nottingham in 2012, hid Thesis was "THE DEFINITION OF ECHINOCOCCUS MULTILOCULARIS DIFFERENTIALLY EXPRESSED MOLECULES USING DEEP SEQUENCING". Recently he has been holding position of Associate Professor at Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences (CAAS) since 2012. His research interests includes Veterinary Parasitology, Parasitology Research, Parasites & Vectors, Molecular and Biochemical Parasitology, Bioscience Reports, Fish and Shellfish Immunology, Parasite Immunology and so on.